Literature DB >> 2924078

Release of 5-hydroxytryptamine, dopamine and noradrenaline in the rat vas deferens in the presence of compound 48/80, veratridine or K+.

S M Celuch1, B D Sloley.   

Abstract

1. The release of 5-hydroxytryptamine (5-HT), dopamine and noradrenaline (NA) from the rat isolated vas deferens was estimated by high performance liquid chromatography with electrochemical detection. 2. Compound 48/80, which is known to release 5-HT and histamine from mast cells, induced a concentration-related, rapid overflow of 5-HT from the rat isolated vas deferens, releasing about 50% of the 5-HT present in the tissue at a concentration of 300 micrograms ml-1. The drug did not induce the release of either dopamine or NA. 3. The depolarizing agents veratridine (10 microM) or K+ (100 mM) induced the release of 5-10% of the 5-HT present in the vas deferens, but did not evoke the overflow of 5-HT from isolated mast cells. 4. Veratridine induced the release of a greater proportion of the dopamine than of the NA contained in the vas deferens (41.0 +/- 5.5 vs 17.9 +/- 2.0%, after 20 min of exposure to the drug, n = 6). In contrast, K+ evoked the release of both amines equally. 5. It is concluded that in the rat vas deferens 5-HT is stored in mast cells and also in cells responsive to depolarizing stimuli. It is suggested that 5-HT could be a neuromodulator or a neurotransmitter in this organ. Veratridine and K+ induce the release of dopamine in addition to NA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2924078      PMCID: PMC1854299          DOI: 10.1111/j.1476-5381.1989.tb11786.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors:  M A Enero; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

3.  Synthesis and uptake of 5-hydroxytryptamine by the myenteric plexus of the guinea-pig ileum. A histochemical study.

Authors:  R G Robinson; M D Gershon
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

4.  Ionic mechanisms involved in the release of 3H-norepinephrine from the cat superior cervical ganglion.

Authors:  E Adler-Graschinsky; E J Filinger; A E Martínez
Journal:  Life Sci       Date:  1984-02-27       Impact factor: 5.037

5.  The effect of veratridine on the release of catecholamines from the perfused adrenal gland.

Authors:  S Ito; Y Nakazato; A Ohga
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

6.  Age-related change in serotonin-mediated prejunctional inhibition of rat vas deferens.

Authors:  H Moritoki; T Iwamoto; J Kanaya; Y Ishida; H Fukuda
Journal:  Eur J Pharmacol       Date:  1986-12-02       Impact factor: 4.432

7.  Dopamine receptors and dopaminergic nerves in the vas deferens of the rat.

Authors:  A Simon; E F Van Maanen
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-07

8.  Serotonin-immunoreactive cells in the superior cervical ganglion of the rat. Evidence for the existence of separate serotonin- and catecholamine-containing small ganglionic cells.

Authors:  A A Verhofstad; H W Steinbusch; B Penke; J Varga; H W Joosten
Journal:  Brain Res       Date:  1981-05-11       Impact factor: 3.252

9.  Identification of and interactions between noradrenergic and serotonergic neurites in the myenteric plexus.

Authors:  M D Gershon; D L Sherman
Journal:  J Comp Neurol       Date:  1982-02-01       Impact factor: 3.215

10.  Release of endogenous 5-hydroxytryptamine from the myenteric plexus of the guinea-pig isolated small intestine.

Authors:  P Holzer; G Skofitsch
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.